近日,旧金山VA医疗中心(SFVAMC)的研究者进行了一项有关艾滋病的新研究,艾滋病患者免疫系统的药理作用增强可以帮助病人剔除HIV病毒感染细胞,这项研究对艾滋病的治疗提供了重要信息。这项研究定位了正在接受抗逆转录病毒治疗的病人潜在的艾滋病毒储存池位置。潜在的HIV储存池建立在患者感染艾滋病毒的最早阶段,此时病人感染了艾滋病毒但不会生产病毒。尽管抗逆转录病毒疗法可以促使血液中的艾滋病毒降低至微量(医疗无法检测到的水平),但HIV病 Researchers at the San Francisco VA Medical Center (SFVAMC) recently conducted a new study on AIDS that enhances the pharmacological effects of the immune system to help patients eliminate HIV-infected cells and provides important information on the treatment of AIDS . The study targeted potential HIV pools in patients undergoing antiretroviral therapy. Potential HIV pools build on the earliest stages of HIV infection in patients, when they become infected with HIV but do not produce the virus. Although antiretroviral therapy can reduce HIV in the blood to trace amounts (undetectable by the medical profession), HIV disease